The estimated Net Worth of Alan Ira Goldberg is at least $794 dollars as of 9 September 2011. Alan Goldberg owns over 2,500 units of Pressure BioSciences stock worth over $794 and over the last 14 years Alan sold PBIO stock worth over $0.
Alan has made over 1 trades of the Pressure BioSciences stock since 2011, according to the Form 4 filled with the SEC. Most recently Alan bought 2,500 units of PBIO stock worth $2,650 on 9 September 2011.
The largest trade Alan's ever made was buying 2,500 units of Pressure BioSciences stock on 9 September 2011 worth over $2,650. On average, Alan trades about 357 units every 0 days since 2010. As of 9 September 2011 Alan still owns at least 28,885 units of Pressure BioSciences stock.
You can see the complete history of Alan Goldberg stock trades at the bottom of the page.
Alan's mailing address filed with the SEC is 1011 GRAND ISLE TERRACE, , PALM BEACH GARDENS, FL, US 33418.
Over the last 21 years, insiders at Pressure BioSciences have traded over $0 worth of Pressure BioSciences stock and bought 433,961 units worth $321,010 . The most active insiders traders include Gregory Gene Freitag, Richard T Schumacher oraz Kevin W Quinlan. On average, Pressure BioSciences executives and independent directors trade stock every 111 days with the average trade being worth of $342. The most recent stock trade was executed by Bradford Addison Young on 31 December 2018, trading 1,579 units of PBIO stock currently worth $3,553.
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the Americas, Europe, Asia, Africa, and Australia. Its pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. It also distributes cell disruption equipment, parts, and consumables. In addition, the company offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. It serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. Pressure BioSciences, Inc. has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was incorporated in 1978 and is based in South Easton, Massachusetts.
Pressure BioSciences executives and other stock owners filed with the SEC include: